Gene Therapy for Severe Crigler Najjar Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gene Therapy for Severe Crigler Najjar Syndrome — Stella

Recruiting

Back to Crigler-Najjar Syndrome trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

France

Hopital Antoine BECLERE, Clamart

Italy

ASST Papa Giovanni XXIII, Bergamo

Azienda Ospedaliera Universitaria Federico II, Naples

Netherlands

AMC, Amsterdam

Key details

Sponsor

Genethon

Enrollment target

~17 participants

Started

March 2018

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

9 Years and older

Last updated March 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov